Eventide Asset Management - STEMLINE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$20,137,000
-54.5%
4,160,6080.0%0.65%
-47.7%
Q4 2019$44,227,000
+2.1%
4,160,6080.0%1.25%
-12.9%
Q3 2019$43,312,000
-11.5%
4,160,608
+30.3%
1.43%
-3.8%
Q2 2019$48,913,000
+136.5%
3,192,727
+98.4%
1.49%
+108.8%
Q1 2019$20,682,000
+100.4%
1,609,523
+48.2%
0.71%
+55.8%
Q4 2018$10,321,000
-42.8%
1,086,4000.0%0.46%
-31.0%
Q3 2018$18,034,000
+3.4%
1,086,4000.0%0.66%
-8.6%
Q2 2018$17,437,000
+4.9%
1,086,4000.0%0.72%
-6.9%
Q1 2018$16,622,000
-1.9%
1,086,4000.0%0.78%
-11.9%
Q4 2017$16,948,000
+40.5%
1,086,4000.0%0.88%
+29.3%
Q3 2017$12,059,000
+20.7%
1,086,4000.0%0.68%
+9.8%
Q2 2017$9,995,000
+7.6%
1,086,4000.0%0.62%
+1.1%
Q1 2017$9,289,000
+2.0%
1,086,400
+27.6%
0.62%
+3.7%
Q4 2016$9,110,000
-1.2%
851,4000.0%0.59%
+5.3%
Q3 2016$9,221,000
+60.0%
851,4000.0%0.56%
+59.5%
Q2 2016$5,764,000
+45.3%
851,4000.0%0.35%
+59.0%
Q1 2016$3,968,000
-26.1%
851,4000.0%0.22%
-17.5%
Q4 2015$5,372,000
-17.2%
851,400
+15.8%
0.27%
-28.6%
Q3 2015$6,490,000
-21.7%
735,000
+4.4%
0.38%
-16.0%
Q2 2015$8,289,000
-7.6%
704,250
+13.6%
0.45%
-33.5%
Q1 2015$8,974,000
-12.4%
620,200
+3.3%
0.68%
-39.6%
Q4 2014$10,245,000
+41.8%
600,500
+3.6%
1.12%
+10.8%
Q3 2014$7,224,000
-12.0%
579,800
+3.6%
1.01%
-9.7%
Q2 2014$8,212,000
+11.3%
559,800
+54.5%
1.12%
-2.4%
Q1 2014$7,378,000
+80.9%
362,400
+74.1%
1.14%
-8.9%
Q4 2013$4,079,000208,1001.26%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q2 2020.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders